cached image

Dennis J. Selkoe, MD

Affiliations: 
Neurology Harvard Medical School, Boston, MA, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=1
Website:
http://selkoelab.bwh.harvard.edu/index.htm
Google:
"Dennis Selkoe"
Cross-listing: Neurotree - Neuropathology Tree

Children

Sign in to add trainee
Carmela R. Abraham grad student Harvard Medical School
Jay H. Chyung grad student 2004 Harvard (Neurotree)
William T. Kimberly grad student 2004 Harvard (Neurotree)
Brian M. Whalen grad student 2005 Harvard (Neurotree)
Matthew L. Hemming grad student 2007 Harvard (Neurotree)
Allen C. Chen grad student 2009 Harvard (Neurotree)
Irit Rappley grad student 2009 Harvard (Neurotree)
Soyon Y. Hong grad student 2012 Harvard (Neurotree)
Heather C. Rice grad student 2013 Harvard (Neurotree)
Edward H. Koo post-doc Harvard Medical School
Matthew J. LaVoie post-doc Brigham and Women's Hospital/Harvard Medical School (Neurotree)
Dominic Walsh post-doc Harvard Medical School - Brigham and Women's Hospital (Neurotree)
Nobuyuki Nukina post-doc 1985-1988 Brigham & Women's Hospital, Harvard Medical School (Neurotree)
Christian Haass post-doc 1990-1992 Brigham and Women's Hospital, Harvard Medical School
Tracy L. Young-Pearse post-doc 2004-2010 Harvard University/Brigham and Women's (Neurotree)
Thomas Koeglsperger post-doc 2008-2011 Harvard Medical School (Neurotree)
Yasuo Ihara research scientist Harvard Medical School
Reisa Sperling research scientist Harvard (Neurotree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chhatwal JP, Schultz AP, Dang Y, et al. (2020) Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals. Nature Communications. 11: 6024
Nuber S, Nam AY, Rajsombath MM, et al. (2020) A stearoyl-CoA desaturase inhibitor prevents multiple Parkinson's disease-phenotypes in α-synuclein mice. Annals of Neurology
Sanderson JB, De S, Jiang H, et al. (2020) Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Communications. 2: fcaa010
Walsh DM, Selkoe DJ. (2020) Amyloid β-protein and beyond: the path forward in Alzheimer's disease. Current Opinion in Neurobiology. 61: 116-124
Mengel D, Liu W, Glynn RJ, et al. (2020) Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase. Alzheimer's Research & Therapy. 12: 27
Cha DJ, Mengel D, Mustapic M, et al. (2019) miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients. Frontiers in Neuroscience. 13: 1208
Wei Z, Meng X, El Fatimy R, et al. (2019) Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways. Neurobiology of Disease. 104617
Imberdis T, Negri J, Ramalingam N, et al. (2019) Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase. Proceedings of the National Academy of Sciences of the United States of America
Liu L, Lauro BM, Ding L, et al. (2019) Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Yang T, Dang Y, Ostaszewski B, et al. (2019) Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF. Annals of Neurology
See more...